Sort by
Refine Your Search
-
Category
-
Country
-
Employer
- International Institute of Molecular and Cell Biology in Warsaw
- RMIT University
- Uppsala University
- ;
- Radboud University Medical Center (Radboudumc)
- Technical University of Munich
- University of Oslo
- ; University of Southampton
- CNRS
- Duke University
- Ilya Pharma
- Institute of Physical Chemistry, Polish Academy of Sciences
- Johannes Gutenberg University Mainz •
- Karolinska Institutet
- Leibniz
- Linköping University
- Stockholm University
- TRON – Translationale Oncology Oncology at the University Medical Center of the Johannes Gutenberg University Mainz •
- Technical University of Denmark
- University of Basel
- University of Florida
- University of Louisville
- University of Pittsburgh
- Université de Caen Normandie
- 14 more »
- « less
-
Field
-
biomarkers for precise disease monitoring. Furthermore, the unique glycan profiles of tumors provide appealing targets for cancer immunotherapy. This project seeks to exploit tumor-specific glycosylation
-
-temporal dynamic organisation of human T cell immunity in tissues. This will bring the next generation of immunotherapies to the level of tissue specificity. The department of Infection Immunology addresses
-
compounds, cancer or immunotherapy research. The candidate should be familiar with air-sensitive chemistry and general analytical techniques such as FTIR, NMR, electrochemistry, etc. Desirable criteria
-
. The position is part of the project entitled “Spatial Determinants of Immunotherapy Resistance in Cancer”, funded by the NCN (National Science Centre) in cooperation with the SNSF (Swiss National Science
-
of the diversity within the T cell immune response. Our long-term goal is that the fundamental knowledge we generate will contribute to improved vaccines and immunotherapies. The Gerlach group is part of
-
of Medicine is seeking a highly motivated scientist to develop immunotherapy strategies for neurological diseases and to identify novel genes that cause neurological diseases development. The candidate will
-
such as immunotherapies are revolutionising cancer treatment. However, as they are not effective in all patients they should be tailored to the right patients while work to identify new drug targets and
-
for a motivated Senior Research Assistant with expertise and knowledge in cancer immunotherapy and genetic engineering of (immune) cells. Join our exciting CAR-NK therapy program and translational
-
. As a PhD candidate you will focus on analyses of patient-related factors for outcome and chemotherapy and immunotherapy treatment response and toxicity in bladder cancer. The candidate will contribute
-
the following areas: cancer precision medicine, cancer immunotherapy, genomics and neurobiology, molecular tools and functional genomics, neuro-oncology and neurodegeneration and vascular biology. Department